MARKET

PLSE

PLSE

Pulse Biosciences Inc
NASDAQ
46.32
-2.22
-4.57%
Pre Market: 46.29 -0.03 -0.06% 09:03 10/15 EDT
OPEN
47.60
PREV CLOSE
48.54
HIGH
48.97
LOW
44.80
VOLUME
1.74K
TURNOVER
0
52 WEEK HIGH
58.90
52 WEEK LOW
12.56
MARKET CAP
3.30B
P/E (TTM)
-39.4381
1D
5D
1M
3M
1Y
5Y
1D
Pulse Biosciences partners Clayman Thyroid Center on nsPFA
TipRanks · 1d ago
Pulse Biosciences Partners With Clayman Thyroid Center To Expand Thyroid Nodule Treatment
NASDAQ · 1d ago
Pulse Biosciences Partners With Clayman Thyroid Center At Hospital For Endocrine Surgery In Tampa, Florida
Benzinga · 1d ago
Pulse Biosciences announces partnership with Clayman Thyroid Center
TipRanks · 1d ago
Pulse Biosciences Is Maintained at Outperform by Oppenheimer
Dow Jones · 1d ago
Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q3
Seeking Alpha · 1d ago
30 U.S. stocks flashing Strong Buy ratings as earnings roll in
Seeking Alpha · 1d ago
Oppenheimer Maintains Outperform on Pulse Biosciences, Raises Price Target to $60
Benzinga · 1d ago
More
About PLSE
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s CellFX Nanosecond Pulsed-Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. It is pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation (AF) and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers, such as surgical soft tissue ablation. Its nsPFA Percutaneous Electrode System consists of a disposable, percutaneous, needle electrode for use with its CellFX Console. Its surgical cardiac ablation clamp is designed for use by cardiac surgeons during the surgical treatment of AF. The CellFX Console is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. It is also developing a Nanosecond PFA 360-degree Cardiac Catheter System.

Webull offers Pulse Biosciences Inc stock information, including NASDAQ: PLSE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLSE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLSE stock methods without spending real money on the virtual paper trading platform.